Andrew John Liu

Associate Professor of Neurology

Neurology, Behavioral Neurology

932 Morreene Rd, Room 258, Durham, NC 27705

https://orcid.org/0000-0003-3096-1788

932 Morreene Rd., Rm 258, Durham, NC 27705

More About This Person

At a Glance

Credentials
1. Education
2. Licensure

Academic Experience

Global Scholarship

Keywords

Research
1. Selected Grants

Scholarly Works

Teaching & Mentoring
1. Teaching Summary
2. Advising & Mentoring Summary

Recognition
1. Academic Honors
2. News Items

Professional Activities

Selected Grants

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Intrathecally Administered ALN-APP in Patients with Cerebral Amyloid Angiopathy (CAA)

Clinical TrialPrincipal Investigator · Awarded by Alnylam Pharmaceuticals · 2025 - 2030

Automated High-purity Exosome isolation-based AD diagnostics system (AHEADx)

ResearchCo-Principal Investigator · Awarded by National Institute on Aging · 2023 - 2028

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer¿s Disease o

Clinical TrialPrincipal Investigator · Awarded by Biogen MA, Inc. · 2023 - 2027

Utility of blood biomarkers for predicting ARIA and its course in MCI and AD subjects undergoing routine clinical treatment

ResearchInvestigator · Awarded by Cure Alzheimer's Fund · 2024 - 2027

Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD

ResearchPrincipal Investigator · Awarded by Aromha, Inc. · 2025 - 2027

Duke Creating ADRD Researchers for the Next Generation - Stimulating Access to Research in Residency Program (CARiNG-StARR)"

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2020 - 2026

Characterizing impaired glymphatic function in patients with cognitive decline with MRI

ResearchCo Investigator · Awarded by GE Medical Systems Information Technologies, Inc. · 2025 - 2026

Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease (R21)

ResearchInvestigator · Awarded by National Institute on Aging · 2023 - 2026

A Diagnostic Test for Dementia with Lewy Bodies

ResearchPrincipal Investigator · Awarded by CND Life Sciences · 2023 - 2026

Establishing novel plasma biomarkers through an unbiased approach to prognosticate TAND

ResearchPrincipal Investigator · Awarded by National Tuberous Sclerosis Association · 2024 - 2025

Adaptive Neuromodulation of Working Memory Networks in Aging and Dementia

ResearchCo Investigator · Awarded by National Institute on Aging · 2022 - 2025

Mis-folded tau based biomarkers for diagnosing and differentiating AD and ADRD

ResearchCollaborator · Awarded by North Carolina Central University · 2023 - 2025

Synuclein-One Study

ResearchPrincipal Investigator · Awarded by CND Life Sciences · 2020 - 2023

Social adversities, epigenetics, and the obesity epidemic

ResearchPrincipal Investigator · Awarded by North Carolina State University · 2017 - 2022